Why the drug development pipeline is not delivering better medicines

被引:29
|
作者
Naci, Huseyin [1 ]
Carter, Alexander W. [2 ]
Mossialos, Elias [1 ]
机构
[1] Univ London London Sch Econ & Polit Sci, Dept Social Policy, LSE Hlth, London WC2A 2AE, England
[2] Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth Innovat, London SW7 2AZ, England
来源
关键词
RESEARCH-AND-DEVELOPMENT; EFFICACY; COST; INNOVATION; SAFETY; FDA; PROMOTION; APPROVAL; MERGERS; GROWTH;
D O I
10.1136/bmj.h5542
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Delivering Better Medicines to ChildrenNeed for Better Integration Between the Science, the Policy, and the Practice
    Madlen Gazarian
    Pediatric Drugs, 2009, 11 (1) : 41 - 44
  • [2] The 'What, Why, Where and How' of Delivering a Drug
    Mukherjee, Kusumika
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2020, 41 (10) : 679 - 680
  • [3] Why drug delivery is the key to new medicines
    Mike May
    Nature Medicine, 2022, 28 : 1100 - 1102
  • [4] Why drug delivery is the key to new medicines
    May, Mike
    NATURE MEDICINE, 2022, 28 (06) : 1100 - 1102
  • [5] Drug development: A healthy pipeline
    Branwen Morgan
    Nature, 2016, 533 : S116 - S117
  • [6] Herding in the drug development pipeline
    Christian Fougner
    Julie Cannon
    Lydia The
    Jeffrey F. Smith
    Olivier Leclerc
    Nature Reviews Drug Discovery, 2023, 22 : 617 - 618
  • [7] Herding in the drug development pipeline
    Fougner, Christian
    Cannon, Julie
    The, Lydia
    Smith, Jeffrey F.
    Leclerc, Olivier
    NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (08) : 617 - 618
  • [9] Delivering living medicines with biomaterials
    Harimoto, Tetsuhiro
    Jung, Wei-Hung
    Mooney, David J.
    NATURE REVIEWS MATERIALS, 2025, 10 (03): : 191 - 210
  • [10] Why drug approval needs better evidence
    Godlee, Fiona
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 353